We are live on ! Find out more
HQY icon

HealthEquity

441 hedge funds and large institutions have $8.66B invested in HealthEquity in 2024 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 162 increasing their positions, 143 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

326% more call options, than puts

Call options by funds: $29.1M | Put options by funds: $6.82M

107% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 43

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

20% more capital invested

Capital invested by funds: $7.24B → $8.66B (+$1.41B)

13% more repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 143

9% more funds holding

Funds holding: 403441 (+38)

2.87% more ownership

Funds ownership: 101.2%104.06% (+2.9%)

Holders
441
Holders Change
+38
Holders Change %
+9.43%
% of All Funds
5.81%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
89
Increased
162
Reduced
143
Closed
43
Calls
$29.1M
Puts
$6.82M
Net Calls
+$22.2M
Net Calls Change
+$13.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
$31.9M +$20.5M +220,451 +197%
AAM
52
Aureus Asset Management
Massachusetts
$31.1M -$9.27M -99,474 -24%
RIM
53
Ranger Investment Management
Texas
$29.3M +$4.21M +45,130 +17%
Bessemer Group
54
Bessemer Group
New Jersey
$28.5M +$10.7M +114,865 +63%
DDC
55
DF Dent & Co
Maryland
$27.6M -$862K -9,249 -3%
SCA
56
Summit Creek Advisors
Minnesota
$27.4M +$2.65M +28,424 +11%
Ensign Peak Advisors
57
Ensign Peak Advisors
Utah
$26.6M -$5.44M -58,354 -17%
Ameriprise
58
Ameriprise
Minnesota
$25.9M +$9.07M +97,329 +56%
ACM
59
Ashford Capital Management
Delaware
$25.8M -$3.35M -35,910 -12%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$25.6M +$94.2K +1,011 +0.4%
Principal Financial Group
61
Principal Financial Group
Iowa
$25.2M +$1.92M +20,563 +8%
Artisan Partners
62
Artisan Partners
Wisconsin
$24.6M +$23.9M +256,051 New
Macquarie Group
63
Macquarie Group
Australia
$23.4M -$4.9M -52,593 -18%
GT
64
Glenmede Trust
Pennsylvania
$23M -$305K -3,268 -1%
AQR Capital Management
65
AQR Capital Management
Connecticut
$22.5M -$13.9M -148,964 -39%
OAM
66
Ophir Asset Management
Australia
$22.1M -$2.03M -21,793 -9%
Victory Capital Management
67
Victory Capital Management
Texas
$21.9M -$3.64M -39,024 -15%
Man Group
68
Man Group
United Kingdom
$20.9M +$530K +5,685 +3%
Retirement Systems of Alabama
69
Retirement Systems of Alabama
Alabama
$20.6M +$44.8K +481 +0.2%
Barclays
70
Barclays
United Kingdom
$19.2M +$3.15M +33,849 +20%
WP
71
Woodline Partners
California
$18M -$13.9M -148,827 -44%
Citigroup
72
Citigroup
New York
$17.7M +$7.68M +82,381 +81%
Natixis Advisors
73
Natixis Advisors
Massachusetts
$17.7M -$2.35M -25,185 -12%
AllianceBernstein
74
AllianceBernstein
Tennessee
$17.3M -$400K -4,290 -2%
Swiss National Bank
75
Swiss National Bank
Switzerland
$16.5M +$168K +1,800 +1%

HQY Hedge Fund Activity: Q4 2024 in Review

441 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q4 2024, worth a combined $8.66B — up 20% from $7.24B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new HQY positions and 43 closed out — a net gain of 46 holders — while 162 added to existing stakes and 143 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $75.9M. The largest seller was Mackenzie Financial, cutting an estimated $39.4M.

  • 441 institutional investors held HealthEquity (HQY) as of Q4 2024, up from 403 in Q3 2024.
  • Funds reported $8.66B of HealthEquity stock for Q4 2024, up 20% quarter-over-quarter.
  • 89 funds opened new HealthEquity positions in Q4 2024 and 43 closed out, a net change of +46 holders.
  • The largest HealthEquity buyer in Q4 2024 was T. Rowe Price Investment Management, an estimated $75.9M added.
  • The largest HealthEquity seller in Q4 2024 was Mackenzie Financial, an estimated $39.4M sold.

Based on aggregated 13F filings for Q4 2024.